全文获取类型
收费全文 | 345篇 |
免费 | 64篇 |
国内免费 | 291篇 |
专业分类
安全科学 | 20篇 |
废物处理 | 20篇 |
环保管理 | 19篇 |
综合类 | 383篇 |
基础理论 | 125篇 |
污染及防治 | 113篇 |
评价与监测 | 18篇 |
社会与环境 | 2篇 |
出版年
2024年 | 3篇 |
2023年 | 11篇 |
2022年 | 23篇 |
2021年 | 14篇 |
2020年 | 32篇 |
2019年 | 21篇 |
2018年 | 19篇 |
2017年 | 38篇 |
2016年 | 41篇 |
2015年 | 43篇 |
2014年 | 30篇 |
2013年 | 41篇 |
2012年 | 42篇 |
2011年 | 47篇 |
2010年 | 34篇 |
2009年 | 22篇 |
2008年 | 17篇 |
2007年 | 27篇 |
2006年 | 39篇 |
2005年 | 25篇 |
2004年 | 22篇 |
2003年 | 19篇 |
2002年 | 13篇 |
2001年 | 13篇 |
2000年 | 9篇 |
1999年 | 13篇 |
1998年 | 5篇 |
1997年 | 6篇 |
1996年 | 8篇 |
1995年 | 7篇 |
1994年 | 4篇 |
1993年 | 6篇 |
1991年 | 2篇 |
1990年 | 3篇 |
1989年 | 1篇 |
排序方式: 共有700条查询结果,搜索用时 31 毫秒
41.
高分子量高纯度阳离子聚丙烯酰胺的合成 总被引:3,自引:0,他引:3
以丙烯酰胺与丙烯酰氧乙基三甲基氯化铵为单体,在复合引发剂的作用下,选择水溶液共聚法合成高分子量与高纯度阳离子型聚丙烯酰胺(CPAM)。实验表明,有机偶氮引发剂A用量0.5‰、氧化还原引发剂用量0.45‰、还原剂与氧化剂摩尔比2∶1、反应体系pH为4与反应时间5 h条件下,CPAM分子量为1 042万,且溶解性好。通过对聚合物残单含量影响因素添加剂用量、反应时间的研究,结果表明,添加剂EDTA和增溶剂D对残留AM含量影响小,而苯甲酸钠对聚合物残留AM的含量影响显著;延长反应时间至7 h,残单含量可降低至0.27%,CPAM的纯度高。通过与国内外3种同类型产品进行对比,结果表明,自制产品的分子量明显高于其他产品,且残单含量比国内产品降低了50%~75%。 相似文献
42.
采用气相分子吸收光谱法测定地表水中硫化物,方法检出限为0.002 mg/L,水样加标回收率为96.5%~107%,精密度(RSD,n=6)为0.08%~1.38%。实验结果表明:该方法准确可靠、灵敏度好、操作简便,适用于地表水中硫化物分析要求。 相似文献
43.
44.
A dynamic flux chamber has been used to estimate fluxes of mercury over different types of surfaces in an abandoned open‐cut mine of Tongren prefecture, Guizhou province, China during spring and summer of 1996. The highest fluxes were obtained over cinnabar slag and contaminated soils, whereas the emissions above cinnabar ore were substantially lower. These fluxes was scaled up to estimate the contribution of mercury emissions to air from mercury wastes, compared to anthropogenic activities in the province of Guizhou, China. Atmospheric mercury concentrations measured were enhanced in the mining area (<1.3 μg m‐3) compared to regional background sites (1.8–5.1 ng m‐3). The spreading of mercury was estimated by using biological and geological samples. Moss bags have been employed to estimate long‐time dry‐ and wet‐deposition to this area. 相似文献
45.
46.
47.
48.
Originally prenatal diagnosis was confined to the diagnosis of metabolic disorders and depended on assaying enzyme levels in amniotic fluid. With the development of recombinant DNA technology, molecular diagnosis became possible for some genetic conditions late in the 1970s. Here we briefly review the history of molecular prenatal diagnostic testing, using Duchenne muscular dystrophy as an example, and describe how over the last 30 years we have moved from offering testing to a few affected individuals using techniques, such as Southern blotting to identify deletions, to more rapid and accurate PCR-based testing which identifies the precise change in dystrophin for a greater number of families. We discuss the potential for safer, earlier prenatal genetic diagnosis using cell free fetal DNA in maternal blood before concluding by speculating on how more recent techniques, such as next generation sequencing, might further impact on the potential for molecular prenatal testing. Progress is not without its challenges, and as cytogenetics and molecular genetics begin to unite into one, we foresee the main challenge will not be in identifying the genetic change, but rather in interpreting its significance, particularly in the prenatal setting where we frequently have no phenotype on which to base interpretation. Copyright © 2010 John Wiley & Sons, Ltd. 相似文献
49.
50.